New report details deadly toll of delayed measles complication in kids

young child with a headache

Sorapop / iStock

Editor's note: The authors of the report were misidentified in the original version of this story. The story has since been corrected. CIDRAP News regrets the error.

Measles is sometimes dismissed as an unserious disease or ‘just a rash.’ But the highly contagious virus can cause serious illness not just during initial infection but years later, after patients appear to have made a full recovery. 

This delayed complication, a rare, almost invariably fatal brain disease known as subacute sclerosing panencephalitis (SSPE), is highlighted in a new report published yesterday in Emerging Infectious Diseases.

For the report, researchers in the Philippines looked at 20 children from that country, where measles outbreaks occurred in 2010–11, 2013, and 2018-19. The most recent outbreak was the largest in the World Health Organization Western Pacific Region. All children in the report were admitted to the pediatric hospital in Quezon City from 2007 through 2022. 

Larger wave of SSPE may be on horizon

All four children with estimated measles infection dates corresponding to the 2018-19 outbreak were hospitalized between 2020 and 2022, two to three years after their initial infections. Because SSPE is latent for years after initial infection, those cases “most likely represent the leading edge of a postoutbreak wave,” notes the report, and “additional cases might emerge over the coming years.”

Ten of the 19 children in the study with an estimable infection age contracted measles before they were old enough for routine vaccination at nine months (when the Philippines schedules its first routine dose). The median age at hospital admission for SSPE was 6.2 years. 

Additional cases might emerge over the coming years.

Eighty-five percent of the children had received at least one measles-containing vaccine, but the report emphasizes that SSPE results from naturally circulating measles that spreads between people, not from the weakened measles virus used in vaccines. 

First-dose vaccine coverage in the Philippines declined from 92% in 2004-07 to 64% in 2021. Reported measles cases climbed from 2,428 in 2017 to 48,525 in 2019.

All 20 children admitted to the hospital for SSPE had worsening brain and nervous system function. All 17 screened for measles antibodies in their cerebrospinal fluid tested positive, and all 13 screened for measles antibodies in their blood tested positive. 

Diagnostic challenges, limitations

The researchers highlight some limitations. A measles history was absent or unknown in one quarter of the observed children, and the researchers recommend strengthened measles surveillance for all children who present with signs of neurodegeneration, regardless of available measles history. 

The study’s small, single-hospital sample couldn’t establish national SSPE rates and infection dates, and vaccination histories relied on caregiver recall and could not be verified. 

Still, the findings underscore the need for stronger measles and SSPE surveillance and sustained two-dose vaccination coverage, including supplementary immunization during outbreaks, the authors conclude. 

This week's top reads

Our underwriters

Unrestricted financial support provided by